Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection.
- 2013-10
- Clinical Trial
- International Immunopharmacology 17(2)
- Eriko Chiba
- Yohsuke Tomosada
- M. G. Vizoso-Pinto
- S. Salva
- Takuya Takahashi
- Kohichiro Tsukida
- H. Kitazawa
- S. Alvarez
- J. Villena
- PubMed: 23838113
- DOI: 10.1016/j.intimp.2013.06.024
10 Insights on
- Improved Immune Response
- Improved Resistance Against Respiratory Syncytial Virus
- Modulated Pulmonary Innate Immune Microenvironment
- Reduced Th2 Reactions
- Improved Resistance to RSV Infection
- Improved Antiviral Immune Response
- Improved Resistance to Infections
- Modulation of Pulmonary Innate Immune Function
- Modulated Pulmonary Innate Immune Response
- Enhanced Pulmonary Immune Response
- Low evidence
- Highly Cited
- Animal Study